Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-03-12 | Keros Therapeutics | Series C | $56M | Arkin Holdings, Cowen, Foresite Capital, OrbiMed Advisors, Partners Healthcare Innovation, Pontifax, Quark Venture, and Venrock |
2018-11-21 | Keros Therapeutics | Series B | $23M | Arkin Holdings, GF Securities, Partners Innovation Fund, Pontifax, and Quark Venture |